2006 Presenting Companies

Agri Food Certification was created to provide non-biased, third party certification programs and assure the traceability of meat and poultry products. Agri Food Certification administers the certification process for the food supply participants who seek certification under the VeriPrime Traceability Assurance System (VTAS) under an exclusive contract from VeriPrime. The VTAS is the only USDA accredited program for certified traceable meat and poultry. It establishes a new Industry Standard and minimum standard of care. The USDA recognized plan calls for industry implementation by October 1, 2006.

HiPer Technology, founded in March 2000, is in the business of developing, manufacturing and marketing products using a new carbon fiber (super-structural) composite resin manufactured using proprietary thick wall molding techniques. The resulting products are targeted to replace similar products presently manufactured from heat-treated aluminum alloys, laminate composites, or non-structural resin. HiPer co-developed this material with E. I DuPont de Nemours (DuPont). Their current primary market are ATV wheels with recent introductions for Micro Sprint Cars and small motorcycles.

ImmunoGenetix Therapeutices, Inc. is a biotechnology company developing advanced DNA immunotherapies for HIV infection. DNA immunotherapies offer a promising approach to reducing the dependency on anti-HIV drug cocktails and diminishing the emergence of drug resistant HIV strains. They are relative inexpensive to produce, readily scaled up, and stable at ambient temperatures. The Company is seeking $4M in financing to complete IND enabling studies, file and launch a clinical trial on its lead product candidate.

Innovia Medical, LLC acquired all of the operating assets of MDI Instruments, Inc. in April 2005, a previously orphaned division of Becton Dickinson, whose FDA approved products utilize the only technology for the rapid detection of middle ear fluid and ear infections. Innovia offers both a professional model (EarCheck® Pro) and a consumer model EarCheck® MEM) with disposable tips for each. Both models of EarCheck use patented Spectral Gradient Acoustic Reflectrometry (SG-AR) technology, which represents the best solution for medical professionals and the only solution for parents to safely, painlessly and quickly test for signs of ear infection in children.

Inverseon is a clinical-stage company re-profiling drugs for chronic diseases, focusing on the long-term effects of drugs versus their short-term effects. Inverseon was founded in 2004, based on technology developed by Richard Bond, PhD, an Associate Professor at the Univeristy of Houston (Texas). Inverseon’s lead drug is an oral, daily therapy for asthma, which has completed a positive Phase IIa proof-of-concept clinical study. Inverseon intends to formulate a controlled-release version and take that into Phase IIb studies for asthma. This opportunity is a new approach to treating asthma, one which should be complementary to and compatible with currently used therapies.

Verenta Pharmaceuticals, LLC is a specialty pharmaceutical company focused on the development and commercialization of new formulations, and prodrugs, of currently marketed prescription products. This approach has several key advantages over the traditional biotechnology/biopharmaceutical company’s emphasis on development and commercialization of new chemical entities (NCEs). Verenta has initiated efforts to develop a new formulation of cyclosporine for the treatment of dry eye and has licensed an improved controlled release version of tramadol.